Regulatory Affairs Syndicator

Regulatory Affairs Updates and Bulletins by Joe Schwoebel

  • Blog
  • Warning Letters
  • FDA Links
  • Resource
  • Register


« US food and drug regulator to add 1300 jobs - CBC.ca
Merck Receives FDA Warning Letter Over Problems at Pennsylvania Plant - Wall Street Journal »

Sucampo shares rise on expanded constipation drug approval - CNNMoney.com

Published by Google Inc. April 30th, 2008 in Google FDA News, Regulatory Affairs

Seeking Alpha

Sucampo shares rise on expanded constipation drug approval
CNNMoney.com - 4 hours ago
… million payment from partner Takeda Pharmaceutical Co., now that the Food and Drug Administration expanded approved use of constipation drug Amitiza. …
Amitiza Treats Irritable Bowel With Constipation U.S. News & World Report
FDA approves irritable bowel drug Reuters
Sucampo Pharma, Takeda get FDA approval for new Amitiza indication Forbes
TechJournal South - Reuters
all 67 news articles


Search



Regulatory Affairs Syndicator is powered by WordPress 2.0.3 and K2 Beta Two r167 by Michael and Chris
RSS Entries and RSS Comments